← All Investors
ANI PHARMACEUTICALS INC
ANIP 2.25 09-01-29
Holders
2
Combined Value
$49M
Combined Shares
40,000,000
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $30M | 0.01% | ~$1.34 | — | Bought Q1 2026 | Q1 2026 |
| Steve Cohen - Point72 | $18M | 0.02% | ~$1.25 | — | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Israel Englander - Millennium Management | SOLD OUT | −$30M | ~$1.26 |
| Q1 2026 | Ken Griffin - Citadel Advisors | BUY | +$12M | ~$1.24 |
| Q1 2026 | Steve Cohen - Point72 | BUY | +$9.3M | ~$1.24 |
| Q4 2025 | Steve Cohen - Point72 | NEW BUY | +$9.5M | ~$1.26 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SELL | −$5.7M | ~$1.26 |
| Q4 2025 | Israel Englander - Millennium Management | BUY | +$3.8M | ~$1.26 |
| Q3 2025 | Israel Englander - Millennium Management | NEW BUY | +$29M | ~$1.41 |
| Q3 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$27M | ~$1.41 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 40,000,000 | −14.0% | $49M | $1.24 |
| Q4 2025 | 3 | 46,500,000 | +14.8% | $58M | $1.26 |
| Q3 2025 | 2 | 40,500,000 | — | $56M | $1.41 |